Credit score: Unsplash/CC0 Public Area
Medical medicine are costly to make and may have an antagonistic impact on the setting. Researchers Stefano Cucurachi and Justin Lian have developed a framework to assist the well being care system assess the financial and environmental sustainability of medical compounds. The analysis is printed within the Proceedings of the Nationwide Academy of Sciences.
With a rising and growing old inhabitants, and extra folks dwelling with continual illness, well being care prices are rising and the pharmaceutical trade is increasing quick. Sufferers and well being care professionals are additionally starting to surprise concerning the environmental impression of medicines. However info on that is missing.
“Some sources claim 10% of all pharmaceuticals have an environmental risk, but only the smallest fraction has ever been assessed,” says Cucurachi, Affiliate Professor of commercial ecology.
Along with environmental engineering postdoc Lian, Cucurachi developed a framework to map each the environmental impression and improvement prices of pharmaceutical elements. The framework can assist information greener decision-making in pharmaceutical manufacturing, and is related to each trade and coverage. The analysis is a part of the LIFE GREENAPI-project.
The researchers primarily based their framework on an environmental and financial evaluation of 9 artificial routes for Molnupiravir, a broad-spectrum antiviral drug used to deal with COVID-19. “We could do this thanks to a collaboration with a Chinese pharmaceutical university that can synthesize active pharmaceutical ingredients,” says Cucurachi.
“We used their primary data to assess the preferable ways of synthesizing this compound from both an environmental sustainability and a cost perspective.”
Lian provides, “We found that solvent use and process design dominate the environmental footprint and the cost of production. Some solvents are quite toxic and have a big impact on the environment, whereas biocatalysts have a low impact and low costs. And they have the potential to be produced on an industrial scale.”
The framework may have a big effect, says Cucurachi. “There’s a lot of scrutiny of pharmaceuticals before they’re administered to humans because of potential adverse effects, but they could also harm the environment. You’d want to know that early on in the drug development process rather than after these substances have been deployed on a large scale.”
A number of Dutch stakeholders have expressed an curiosity within the researchers’ framework. “We’re currently involved in Enkore, a large European research project with partners from the whole health care system value chain: from pharmaceutical companies to hospitals, and patient representatives to company innovators. As researchers, we’re constantly being asked to join these kinds of initiatives—that was unheard of two or three years ago.”
Extra info:
Zhengyun Chen et al, Divergent sustainability profiles of molnupiravir synthesis routes are ruled by solvent use and course of design, Proceedings of the Nationwide Academy of Sciences (2025). DOI: 10.1073/pnas.2502336122
Supplied by
Leiden College
Quotation:
Researchers pioneer ‘inexperienced’ framework for sustainable drug improvement (2025, October 14)
retrieved 14 October 2025
from https://medicalxpress.com/information/2025-10-green-framework-sustainable-drug.html
This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
